Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Real-World Use of an iPad-Based Light Therapy App, With Optional Biomarker Collection

NCT: NCT07744711 · ENROLLING_BY_INVITATION

NCT IDNCT07744711
StatusENROLLING_BY_INVITATION
Start Date2026-07-17
Completion2028-06-30
SponsorCircadian OS, Inc (INDUSTRY)
First posted
Last updated

Brief Summary

This study looks at how adults use an iPad-based light app in everyday life. Light is the main signal that sets the body's internal clock, which controls daily rhythms in sleep, alertness, and many other body systems. Indoor living means many people do not get bright light at a consistent time each day. The app uses the iPad screen to deliver light while people watch videos, read, or browse. It suggests about one hour of use per day, started within about two hours of waking. It does not require anyone to follow that schedule, and no one is locked out for using it more, less, or at other times. The app shows people when they are positioned to receive the intended light, records how the app is used, and asks short questions about sleep. The main questions this study aims to answer are: 1. How often, how long, and at what time of day do people use the app? 2. What do people mostly do during light-delivery sessions? 3. What do people think of the app, and how easy is it to use? Participants will use the app on an iPad for up to eight weeks, answer short questions about their sleep and how they feel, and share feedback about their experience. Participants may also choose to take part in optional sub-studies. They can wear a device the sponsor provides to record movement, light exposure, and skin temperature, or share data from a wearable device they already use. They can also give blood, saliva, or urine samples, which researchers will use to describe daily patterns in clock-related genes and other markers. These sub-studies are entirely exploratory and voluntary, and participants can take part in the main study without them. Participants will not receive results from any samples they give. This study does not provide medical treatment, and it is not designed to determine whether the app treats or improves any medical condition.

Frequently Asked Questions

What is Real-World Use of an iPad-Based Light Therapy App, With Optional Biomarker Collection?

Real-World Use of an iPad-Based Light Therapy App, With Optional Biomarker Collection is a clinical trial registered under NCT07744711. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07744711?

The current status of NCT07744711 (Real-World Use of an iPad-Based Light Therapy App, With Optional Biomarker Collection) is: ENROLLING_BY_INVITATION.

When did Real-World Use of an iPad-Based Light Therapy App, With Optional Biomarker Collection start?

Real-World Use of an iPad-Based Light Therapy App, With Optional Biomarker Collection started on 2026-07-17.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.